biblio

Filters: Author is Belekar, Meenakshi A.  [Clear All Filters]
2018
G. Subramanian, “Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules”, mSphere, vol. 3, no. 1, pp. e00534-17, 2018.
2019
B. Subramani, Shantamurthy, C. D., Maru, P., Belekar, M. A., Mardhekar, S., Shanmugam, D., and Kikkeri, R., “Demystifying a hexuronic acid ligand that recognizes Toxoplasma gondii and blocks its invasion into host cells”, Organic & Biomolecular Chemistry, vol. 17, no. 18, pp. 4535-4542, 2019.
G. Subramanian, Belekar, M. A., Shukla, A., Tong, J. Xin, Sinha, A., Chu, T. T. T., Kulkarni, A. S., Preiser, P. R., D. Reddy, S., Tan, K. S. W., Shanmugam, D., and Chandramohanadas, R., “Targeted phenotypic screening in plasmodium falciparum and toxoplasma gondii reveals novel modes of action of medicines for malaria venture malaria box molecules (vol 3, e00534-17, 2018)”, MSphere, vol. 4, no. 2, pp. e00159-19, 2019.
2020
A. Tanala Patra, Hingamire, T., Belekar, M. A., Xiong, A., Subramanian, G., Bozdech, Z., Preiser, P., Shanmugam, D., and Chandramohanadas, R., “Whole-cell phenotypic screening of medicines for malaria venture pathogen box identifies specific inhibitors of plasmodium falciparum late-stage development and egress”, Antimicrobial Agents and Chemotherapy, vol. 64, no. 5, pp. e01802-19, 2020.